Jacobs Levy Equity Management’s AngioDynamics ANGO Stock Holding History

Jacobs Levy Equity Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.48M	Buy	+218,382	New	+$2.37M	0.01%	542
2025 Q2	–	Sell	-38,900	Closed	-$365K	–	1032
2025 Q1	$365K	Sell	38,900 -483,049	-93%	-$5.08M	﹤0.01%	956
2024 Q4	$4.78M	Buy	521,949 +107,829	+26%	+$793K	0.02%	442
2024 Q3	$3.22M	Sell	414,120 -95,157	-19%	-$687K	0.01%	513
2024 Q2	$3.08M	Sell	509,277 -176,763	-26%	-$1.09M	0.01%	529
2024 Q1	$4.03M	Sell	686,040 -156,261	-19%	-$928K	0.02%	466
2023 Q4	$6.6M	Buy	842,301 +128,402	+18%	+$891K	0.03%	374
2023 Q3	$5.22M	Buy	713,899 +274,210	+62%	+$2.28M	0.03%	373
2023 Q2	$4.59M	Buy	439,689 +217,252	+98%	+$2.09M	0.03%	412
2023 Q1	$2.3M	Buy	222,437 +204,628	+1,149%	+$2.62M	0.01%	547
2022 Q4	$245K	Buy	+17,809	New	+$248K	﹤0.01%	883
2022 Q2	–	Sell	-20,742	Closed	-$447K	–	995
2022 Q1	$447K	Sell	20,742 -64,848	-76%	-$1.47M	﹤0.01%	878
2021 Q4	$2.36M	Sell	85,590 -3,258	-4%	-$89.9K	0.02%	585
2021 Q3	$2.31M	Hold	88,848	–	–	0.02%	586
2021 Q2	$2.41M	Sell	88,848 -21,374	-19%	-$522K	0.02%	562
2021 Q1	$2.58M	Sell	110,222 -81,154	-42%	-$1.64M	0.02%	545
2020 Q4	$2.93M	Buy	191,376 +15,799	+9%	+$200K	0.03%	498
2020 Q3	$2.12M	Buy	+175,577	New	+$1.67M	0.02%	509
2020 Q1	–	Sell	-35,597	Closed	-$570K	–	999
2019 Q4	$570K	Buy	+35,597	New	+$544K	0.01%	768
2018 Q4	–	Sell	-23,864	Closed	-$519K	–	976
2018 Q3	$519K	Sell	23,864 -191,214	-89%	-$4.25M	0.01%	770
2018 Q2	$4.78M	Buy	215,078 +630	+0.3%	+$12.9K	0.08%	316
2018 Q1	$3.7M	Buy	214,448 +21,402	+11%	+$357K	0.06%	345
2017 Q4	$3.21M	Buy	193,046 +58,632	+44%	+$1M	0.06%	362
2017 Q3	$2.3M	Sell	134,414 -9,600	-7%	-$161K	0.04%	413
2017 Q2	$2.33M	Sell	144,014 -15,902	-10%	-$251K	0.05%	396
2017 Q1	$2.77M	Sell	159,916 -1,400	-0.9%	-$23.4K	0.06%	352
2016 Q4	$2.72M	Buy	161,316 +139,116	+627%	+$2.32M	0.05%	363
2016 Q3	$389K	Sell	22,200 -1,300	-6%	-$21.1K	0.01%	754
2016 Q2	$338K	Hold	23,500	–	–	0.01%	853
2016 Q1	$289K	Buy	+23,500	New	+$260K	0.01%	880
2014 Q4	–	Sell	-11,599	Closed	-$159K	–	813
2014 Q3	$159K	Sell	11,599 -20,315	-64%	-$290K	﹤0.01%	770
2014 Q2	$521K	Buy	+31,914	New	+$462K	0.01%	624
2013 Q3	–	Sell	-33,767	Closed	-$381K	–	921
2013 Q2	$381K	Buy	+33,767	New	+$359K	0.01%	782

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Jacobs Levy Equity Management's ANGO Position: Q1 2026 in Review

Jacobs Levy Equity Management opened a new position in AngioDynamics (ANGO) in Q1 2026: 218,382 shares worth $2.48M. The stake represents 0.01% of the portfolio and ranks #542 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in ANGO as recently as Q1 2025.

Jacobs Levy Equity Management first reported a position in ANGO in Q2 2013 and has held it in 33 quarters since. The position peaked at $6.6M in Q4 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Jacobs Levy Equity Management held 218,382 shares of AngioDynamics worth $2.48M as of Q1 2026.
AngioDynamics was a new Jacobs Levy Equity Management position in Q1 2026.
AngioDynamics made up 0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #542 holding.
Jacobs Levy Equity Management first reported a position in AngioDynamics in Q2 2013 and has held it in 33 quarters since.
Jacobs Levy Equity Management's AngioDynamics position peaked at $6.6M in Q4 2023.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.